Home/Pipeline/RN5681

RN5681

ASCVD (PCSK9-Lp(a))

PreclinicalActive

Key Facts

Indication
ASCVD (PCSK9-Lp(a))
Phase
Preclinical
Status
Active
Company

About Rona Therapeutics

A clinical-stage biotech developing long-acting siRNA therapeutics for metabolic and degenerative diseases using proprietary liver and extrahepatic delivery platforms.

View full company profile